These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
463 related articles for article (PubMed ID: 21194943)
1. Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors. Gaspar A; Reis J; Fonseca A; Milhazes N; Viña D; Uriarte E; Borges F Bioorg Med Chem Lett; 2011 Jan; 21(2):707-9. PubMed ID: 21194943 [TBL] [Abstract][Full Text] [Related]
2. Selected chromone derivatives as inhibitors of monoamine oxidase. Legoabe LJ; Petzer A; Petzer JP Bioorg Med Chem Lett; 2012 Sep; 22(17):5480-4. PubMed ID: 22850212 [TBL] [Abstract][Full Text] [Related]
3. Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B. Alcaro S; Gaspar A; Ortuso F; Milhazes N; Orallo F; Uriarte E; Yáñez M; Borges F Bioorg Med Chem Lett; 2010 May; 20(9):2709-12. PubMed ID: 20382016 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives. Legoabe LJ; Petzer A; Petzer JP Eur J Med Chem; 2012 Mar; 49():343-53. PubMed ID: 22309913 [TBL] [Abstract][Full Text] [Related]
5. Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors. Gaspar A; Silva T; Yáñez M; Vina D; Orallo F; Ortuso F; Uriarte E; Alcaro S; Borges F J Med Chem; 2011 Jul; 54(14):5165-73. PubMed ID: 21696156 [TBL] [Abstract][Full Text] [Related]
6. Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors. Pisani L; Catto M; Nicolotti O; Grossi G; Di Braccio M; Soto-Otero R; Mendez-Alvarez E; Stefanachi A; Gadaleta D; Carotti A Eur J Med Chem; 2013; 70():723-39. PubMed ID: 24231308 [TBL] [Abstract][Full Text] [Related]
7. Novel sulfanylphthalimide analogues as highly potent inhibitors of monoamine oxidase B. Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP Bioorg Med Chem Lett; 2012 Nov; 22(21):6632-5. PubMed ID: 23010267 [TBL] [Abstract][Full Text] [Related]
8. Pyrazoline based MAO inhibitors: synthesis, biological evaluation and SAR studies. Jagrat M; Behera J; Yabanoglu S; Ercan A; Ucar G; Sinha BN; Sankaran V; Basu A; Jayaprakash V Bioorg Med Chem Lett; 2011 Jul; 21(14):4296-300. PubMed ID: 21680183 [TBL] [Abstract][Full Text] [Related]
9. Structural Exploration of Synthetic Chromones as Selective MAO-B Inhibitors: A Mini Review. Mathew B; Mathew GE; Petzer JP; Petzer A Comb Chem High Throughput Screen; 2017; 20(6):522-532. PubMed ID: 28245770 [TBL] [Abstract][Full Text] [Related]
11. Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors. Reis J; Cagide F; Chavarria D; Silva T; Fernandes C; Gaspar A; Uriarte E; Remião F; Alcaro S; Ortuso F; Borges F J Med Chem; 2016 Jun; 59(12):5879-93. PubMed ID: 27244485 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives. Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of monoamine oxidase by indole and benzofuran derivatives. Prins LH; Petzer JP; Malan SF Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors. Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives. Secci D; Carradori S; Bolasco A; Chimenti P; Yáñez M; Ortuso F; Alcaro S Eur J Med Chem; 2011 Oct; 46(10):4846-52. PubMed ID: 21872365 [TBL] [Abstract][Full Text] [Related]
16. Investigations on the 2-thiazolylhydrazyne scaffold: synthesis and molecular modeling of selective human monoamine oxidase inhibitors. Chimenti F; Bolasco A; Secci D; Chimenti P; Granese A; Carradori S; Yáñez M; Orallo F; Ortuso F; Alcaro S Bioorg Med Chem; 2010 Aug; 18(15):5715-23. PubMed ID: 20615716 [TBL] [Abstract][Full Text] [Related]
17. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor. Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors. Matos MJ; Viña D; Picciau C; Orallo F; Santana L; Uriarte E Bioorg Med Chem Lett; 2009 Sep; 19(17):5053-5. PubMed ID: 19628387 [TBL] [Abstract][Full Text] [Related]
19. Homoisoflavonoids: natural scaffolds with potent and selective monoamine oxidase-B inhibition properties. Desideri N; Bolasco A; Fioravanti R; Monaco LP; Orallo F; Yáñez M; Ortuso F; Alcaro S J Med Chem; 2011 Apr; 54(7):2155-64. PubMed ID: 21405131 [TBL] [Abstract][Full Text] [Related]
20. In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors. Pisani L; Farina R; Nicolotti O; Gadaleta D; Soto-Otero R; Catto M; Di Braccio M; Mendez-Alvarez E; Carotti A Eur J Med Chem; 2015 Jan; 89():98-105. PubMed ID: 25462230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]